|
|
Article: BIOTECHNICA PARTNERING DRUG/DEVICE COMBOS COULD SALVAGE DROPPED COMPOUNDS.
- Article from:
- BIOWORLD Today
- Article date:
- October 11, 2007
- Author:
CopyrightCOPYRIGHT 2007 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Jennifer Boggs, Staff Writer
HANOVER, Germany - With nine out of 10 drugs in development falling to the wayside on the road to market, biotech and pharma could find new opportunities for those stalled programs by partnering with device firms to look at different delivery methods, panelists suggested at the Biotechnica Partnering conference here.
The two-day conference, part of the annual Biotechnica trade show at the Hanover Fair Grounds, began with a panel chaired by BioWorld's Michael Harris on drug/device combination products and the valuation of those products to drug and device companies. While the idea of mixing drugs and devices ...